<Suppliers Price>

RP106

Names

[ CAS No. ]:
496864-15-4

[ Name ]:
RP106

[Synonym ]:
7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine
7-n-Butyl-6-(4-hydroxyphenyl)[5H]-pyrrolo[2,3-b]pyrazine

Biological Activity

[Description]:

Aloisine RP106 (compound 38) is a potent inhibitor of Cdk1/cyclin B, Cdk5/p25, and GSK3 with IC50s of 0.70µM, 1.5µM, 0.92 µM, respectively[1].

[Related Catalog]:

Signaling Pathways >> Stem Cell/Wnt >> GSK-3
Signaling Pathways >> Cell Cycle/DNA Damage >> CDK
Research Areas >> Neurological Disease
Signaling Pathways >> PI3K/Akt/mTOR >> GSK-3

[Target]

Cdk1/cyclin B:0.7 μM (IC50)

Cdk5/p25:1.5 μM (IC50)

GSK-3:0.92 μM (IC50)


[References]

[1]. Yvette Mettey, et al. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. J Med Chem. 2003 Jan 16;46(2):222-36.

Chemical & Physical Properties

[ Density]:
1.155g/cm3

[ Melting Point ]:
182-184ºC

[ Molecular Formula ]:
C16H17N3O

[ Molecular Weight ]:
267.32600

[ Exact Mass ]:
267.13700

[ PSA ]:
61.80000

[ LogP ]:
3.67310

[ Index of Refraction ]:
1.613

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H319-H335-H413

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ RIDADR ]:
NONH for all modes of transport


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.